Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis

Rhinology

Volumn 49, Issue 2, 2011, Pages 155-162

  Ingrand, I ^a   Ingrand, P ^a   Gilbert Dussardier, B ^a   Defossez, G ^a   Jouhet, V ^a   Migeot, V ^a   Dufour, X ^a   Klossek, J M ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Epistaxis; Hereditary hemorrhagic telangiectasia; Osler Rendu Weber disease; Quality of life

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; EPISTAXIS; FEMALE; HEALTH SURVEY; HUMAN; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENT DISEASE; RENDU OSLER WEBER DISEASE; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EPISTAXIS; FEMALE; HEALTH STATUS INDICATORS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; YOUNG ADULT;

EID: 80051554515     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhino09.138     Document Type: Article

References (24)

1. Thomas B, Eyries M, Montagne K et al. Altered endothelial gene expression associated with hereditary haemorrhagic telangiectasia. Eur J Clin Invest 2007; 37: 580-588.
2. Bideau A, Plauchu H, Brunet G, Robert J. Epidemiological investigation of Rendu-Osler disease in France: its geographical distribution and prevalence. Popul. 1989; 44: 3-22.
3. Guttmacher AE, Marchuk DA, White RI, Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995; 333: 918-924.
4. Shovlin CL, Guttmacher AE, Buscarini E et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000; 91: 66-67.
5. Sadick H, Fleischer I, Goessler U, et al. Twenty-four-hour and annual variation in onset of epistaxis in Osler disease. Chronobiol Int. 2007; 24: 357-364.
6. de Gussem EM, Snijder RJ, Disch FJ, et al. The effect of N-acetylcysteine on epistaxis and quality of life in patients with HHT: a pilot study. Rhinology 2009; 47: 85-88.
7. Slotosch D, Koller M, Werner JA, et al. Recurrent nosebleeds in patients with hereditary hemorrhagic telangiectasia. Dtsch Med Wochenschr. 2006; 131: 535-539.
8. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993; 118: 622-629.
9. Pasculli G, Resta F, Guastamacchia E, et al. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res. 2004; 13: 1715-1723.
10. Lennox PA, Hitchings AE, Lund VJ, et al. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol. 2005; 19: 71-74.
11. Geisthoff UW, Heckmann K, D'Amelio R et al. Health-related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2007; 136: 726-33; discussion 734-735.
12. Al-Deen S, Bachmann-Harildstad G. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Rhinology 2008; 46: 281-284.
13. Hitchings AE, Lennox PA, Lund VJ, et al. The effect of treatment for epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol. 2005; 19: 75-78.
14. Karapantzos I, Tsimpiris N, Goulis DG, et al. Management of epistaxis in hereditary hemorrhagic telangiectasia by Nd: YAG laser and quality of life assessment using the HR-QoL questionnaire. Eur Arch Otorhinolaryngol. 2005; 262: 830-833.
15. Leplège A, Ecosse E, Pouchot J, et al. Le questionnaire MOS SF 36 Manuel de l'utilisateur et guide d'interprétation des scores. Paris ESTEM 2001.
16. Jenkins CD, Stanton BA, Niemcryk SJ, et al. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988; 41: 313-321.
17. Piccirillo JF, Merritt MG, Jr., Richards ML. Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20). Otolaryngol Head Neck Surg. 2002; 126: 41-47.
18. Nunnally JC. Psychometric theory 2nd Edit New York: McGraw-Hill 1978.
19. Boyle GJ. Does item homogeneity indicate internal consistency or item redundancy in psychometric scales? Personality and Individual Differences. 1991; 12: 291-294.
20. Pedhazur EJ, Pedhazur Schmelkin L. Measurement, design and analysis an integrated approach Hilldale, NJ Lawrence Erlbaum Associates. 1991.
21. Alobid I, Bernal-Sprekelsen M, Mullol J. Chronic rhinosinusitis and nasal polyps: the role of generic and specific questionnaires on assessing its impact on patient's quality of life. Allergy 2008; 63: 1267-1279.
22. Apolone G, Mosconi P. Satisfaction surveys: do we really need new questionnaires? Int J Qual Health Care 2005; 17: 463-464.
23. Pfister M, Zalaman IM, Blumenstock G, et al. Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Acta Otolaryngol 2008: 1-5.
24. Wyrwich KW, Tierney WM, Babu AN, et al. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005; 40: 577-591.